133 related articles for article (PubMed ID: 4146270)
1. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
Nakayama K; Koike H; Oshima T; Hashimoto K
Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
[No Abstract] [Full Text] [Related]
2. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
Diederich KW; Boyksen D
Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
[No Abstract] [Full Text] [Related]
3. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
von Philipsborn G
Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
[No Abstract] [Full Text] [Related]
4. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
Femmer K; Grünheid K
Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
[No Abstract] [Full Text] [Related]
5. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
[No Abstract] [Full Text] [Related]
6. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
Somani P
Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
[No Abstract] [Full Text] [Related]
7. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
Sano N; Kawada M; Fukutomi Y
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
[No Abstract] [Full Text] [Related]
8. [Effect of ajmaline and its therapeutically used derivatives N-propylajmaline and di-monochloracetylajmaline on the functional refractory period and contractility of guinea pig atrium and aconitine arrhythmia in the rat].
Raschack VM
Arzneimittelforschung; 1975 Apr; 25(4):639-41. PubMed ID: 50847
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
Laddu AR
Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
[No Abstract] [Full Text] [Related]
10. [Effect of ajmaline on the cardiovascular action of ouabain in dogs].
Saito T
Nihon Yakurigaku Zasshi; 1968 Nov; 64(6):625-31. PubMed ID: 5751258
[No Abstract] [Full Text] [Related]
11. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Bianchi C; Sanna GP; Turba C
Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
[No Abstract] [Full Text] [Related]
12. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
Laddu R
Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
[No Abstract] [Full Text] [Related]
13. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
So CS; Oversohl K; Seidl KF
Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
[No Abstract] [Full Text] [Related]
14. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
Schmid JR; Hanna C
J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
[No Abstract] [Full Text] [Related]
15. [Experimental study of the use of magnesium and of ajmaline in ventricular bathmotropic disorders secondary to acute coronary occlusion].
Critelli G; Cernigliaro C; Rizzo S; Santucci A; Marigliano V; Giuliano G
Atti Soc Ital Cardiol; 1969 Jan; 2():270-81. PubMed ID: 5406542
[No Abstract] [Full Text] [Related]
16. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
Nakayama K; Oshima T; Koike H
Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
[TBL] [Abstract][Full Text] [Related]
17. The influence of PGF2 alpha on experimental arrhythmias.
Förster W; Mest HJ; Mentz P
Prostaglandins; 1973 Jun; 3(6):895-904. PubMed ID: 4729607
[No Abstract] [Full Text] [Related]
18. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
19. Cardiac output, heart rate, and blood pressure as influenced by equi-antiarrhythmic doses of eight antifibrillatory agents.
Strubelt O; Back G; Uhl E; Zetler G
Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(4):346-60. PubMed ID: 4257638
[No Abstract] [Full Text] [Related]
20. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT
J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
